5 Einträge gefunden

1. Plain language summary of the MAIA study of daratumumab plus lenalidomide and dexamethasone for the treatment of people with newly diagnosed multiple myeloma

   1. Facon, Thierry
   2. Kumar, Shaji K
   3. Plesner, Torben
   4. Orlowski, Robert Z
   5. Moreau, Philippe
   6. Bahlis, Nizar
   7. Basu, Supratik

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group

   1. Moreau, Philippe
   2. Kumar, Shaji K
   3. San Miguel, Jesús
   4. Davies, Faith
   5. Zamagni, Elena
   6. Bahlis, Nizar
   7. Ludwig, Heinz

   2021 - Forschungsinformationssystem des UKE
3. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial

   1. Facon, Thierry
   2. Kumar, Shaji K
   3. Plesner, Torben
   4. Orlowski, Robert Z
   5. Moreau, Philippe
   6. Bahlis, Nizar
   7. Basu, Supratik

   2021 - Forschungsinformationssystem des UKE
4. Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials

   1. Gavriatopoulou, Maria
   2. Chari, Ajai
   3. Chen, Christine
   4. Bahlis, Nizar
   5. Vogl, Dan T
   6. Jakubowiak, Andrzej
   7. Dingli, David

   2020 - Forschungsinformationssystem des UKE
5. Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma

   1. Facon, Thierry
   2. Kumar, Shaji
   3. Plesner, Torben
   4. Orlowski, Robert Z
   5. Moreau, Philippe
   6. Bahlis, Nizar
   7. Basu, Supratik

   2019 - Forschungsinformationssystem des UKE